仙琚制药(002332) - 2019 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 32.54% to CNY 117,116,082.56 for the reporting period[10] - Operating revenue for the period was CNY 909,294,905.00, reflecting a 2.02% increase year-on-year[10] - Basic earnings per share rose by 30.00% to CNY 0.13 for the reporting period[10] - The net profit after deducting non-recurring gains and losses increased by 38.20% to CNY 119,868,861.00[10] - The net profit for the current period reached ¥130,796,187.47, compared to ¥97,431,768.58 in the previous period, indicating a growth of about 34.2%[63] - The total profit for the current period was ¥404,461,470.76, compared to ¥305,352,572.43 in the previous period, reflecting an increase of about 32.41%[76] - The profit attributable to the parent company's shareholders was ¥290,822,049.48, up from ¥211,667,094.16, which is an increase of approximately 37.36%[76] - The total comprehensive income for the current period was ¥325,483,834.00, compared to ¥230,869,453.08 in the previous period, indicating a growth of about 41.00%[80] Assets and Liabilities - Total assets increased by 7.31% to CNY 5,840,943,609.42 compared to the end of the previous year[10] - The company's total assets amounted to ¥3,812,850,626.01, compared to ¥3,668,116,819.21 in the previous year, marking an increase of about 3.9%[55] - The total liabilities decreased slightly to ¥1,246,286,286.96 from ¥1,257,599,287.85, showing a reduction of about 0.9%[52] - The company reported a decrease in accounts payable to ¥111,154,057.73 from ¥169,743,819.58, a decline of approximately 34.4%[52] - The total liabilities amounted to 2,732,960,522.70 CNY, unchanged from the previous period[112] - The company’s long-term borrowings were recorded at 1,070,951,114.29 CNY, unchanged from the previous period[109] Cash Flow - The net cash flow from operating activities decreased by 64.12% to CNY 54,259,401.20 compared to the same period last year[10] - Cash flow from operating activities generated a net inflow of CNY 402,960,442.22, up from CNY 237,880,404.02 in the prior period, showcasing strong operational performance[88] - The company reported a net cash outflow from investing activities of CNY -233,697,979.17, a decline from a net inflow of CNY 27,620,061.76 in the prior period, indicating increased investment expenditures[93] - Cash flow from financing activities resulted in a net outflow of CNY -38,500,611.59, an improvement from a net outflow of CNY -93,456,544.66 in the previous year[93] Shareholder Information - The company reported a total of 26,000 shareholders at the end of the reporting period[15] - The largest shareholder, Xianju County State-owned Assets Investment Group, holds 21.55% of the shares[15] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[20] Research and Development - Research and development expenses increased by 31.79% year-on-year, an increase of 26.49 million yuan, mainly due to increased R&D expenditures[25] - Research and development expenses increased significantly to ¥38,580,047.98 from ¥19,783,317.76, marking a rise of approximately 94.8%[67] - The company's R&D expenses increased to ¥109,797,711.66 from ¥83,312,630.38, marking a rise of about 31.93%[73] Income and Other Revenue - Other income increased by 71.12% year-on-year, an increase of 7.70 million yuan, mainly due to increased subsidy income[25] - Investment income increased by 130.09% year-on-year, an increase of 11.82 million yuan, mainly due to increased profits from associated companies[25] - Cash received from tax refunds increased by 14,224.26% year-on-year, an increase of 16.19 million yuan, mainly due to export tax rebates received[25] - The investment income from joint ventures and associates was ¥3,541,188.98, significantly higher than ¥1,217,702.80 in the previous period, reflecting an increase of approximately 190.5%[63] - The company experienced a significant increase in investment income, which rose to ¥18,533,016.01 from ¥10,830,223.32, representing a growth of approximately 71.00%[73] Cost Management - Total operating costs decreased to ¥754,198,140.59 from ¥763,231,704.00, reflecting a reduction of about 1.4%[56] - The company paid CNY 212,288,576.27 for goods and services, a decrease from CNY 229,851,818.97 in the prior period, suggesting improved cost management[99]